138 related articles for article (PubMed ID: 3409938)
1. Detection of malignant pleural effusions by tumor marker evaluation.
Pavesi F; Lotzniker M; Cremaschi P; Marbello L; Acquistapace L; Moratti R
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1005-11. PubMed ID: 3409938
[TBL] [Abstract][Full Text] [Related]
2. Combined effusion fluid tumor marker assay, carcinoembryonic antigen (CEA) and human chorionic gonadotropin (hCG), in the detection of malignant tumors.
Couch WD
Cancer; 1981 Dec; 48(11):2475-9. PubMed ID: 7296495
[TBL] [Abstract][Full Text] [Related]
3. Value of human chorionic gonadotropin compared to CEA in discriminating benign from malignant effusions.
Lamerz R; Stoetzer OJ; Mezger J; Brandt A; Darsow M; Wilmanns W
Anticancer Res; 1999; 19(4A):2421-5. PubMed ID: 10470169
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
Salama G; Miédougé M; Rouzaud P; Mauduyt MA; Pujazon MC; Vincent C; Carles P; Serre G
Br J Cancer; 1998; 77(3):472-6. PubMed ID: 9472646
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of tumor markers in pleural effusions].
Botte G; Laferrere L; Etchepare S; Dalurzo D; Duhart JE; Adaro FV
Medicina (B Aires); 1990; 50(3):213-6. PubMed ID: 2130207
[TBL] [Abstract][Full Text] [Related]
9. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of carcinoembryonic antigen (CEA) assay in pleural effusions.
Pierucci G; Lucivero G; Amoruso C; Bonomo L
Tumori; 1984 Oct; 70(5):421-5. PubMed ID: 6506227
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen levels in benign and malignant pleural effusions.
Rittgers RA; Loewenstein MS; Feinerman AE; Kupchik HZ; Marcel BR; Koff RS; Zamcheck N
Ann Intern Med; 1978 May; 88(5):631-4. PubMed ID: 646246
[TBL] [Abstract][Full Text] [Related]
12. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of pleural effusions: clinical usefulness of cell marker quantitation.
Vladutiu AO; Brason FW; Adler RH
Chest; 1981 Mar; 79(3):297-301. PubMed ID: 6162619
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated trypsin inhibitor (TATI) in pleural effusions.
Rapellino M; Pecchio F; Baldi S; Adamo MR; Macri M; Ricardi G
Scand J Clin Lab Invest Suppl; 1991; 207():47-9. PubMed ID: 1780690
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions.
Alataş F; Alataş O; Metintaş M; Colak O; Harmanci E; Demir S
Lung Cancer; 2001 Jan; 31(1):9-16. PubMed ID: 11162861
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Martinez-Vea A; Gatell JM; Segura F; Heiman C; Elena M; Ballesta AM; Mundo MR
Cancer; 1982 Nov; 50(9):1783-8. PubMed ID: 6180821
[TBL] [Abstract][Full Text] [Related]
17. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
18. Tumor markers in pleural effusion diagnosis.
Tamura S; Nishigaki T; Moriwaki Y; Fujioka H; Nakano T; Fujii J; Yamamoto T; Nabeshima K; Hada T; Higashino K
Cancer; 1988 Jan; 61(2):298-302. PubMed ID: 3275487
[TBL] [Abstract][Full Text] [Related]
19. Elevated level of carcinoembryonic antigen in nonmalignant pleural effusions.
Garcia-Pachon E; Padilla-Navas I; Dosda MD; Miralles-Llopis A
Chest; 1997 Mar; 111(3):643-7. PubMed ID: 9118701
[TBL] [Abstract][Full Text] [Related]
20. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
